Zhuhai Kairui Biotech Co., Ltd. announced that it has received CNY 100 million in funding from Shanghai Yanghe Investment Management Co., Ltd., Guangzhou Jet Bio-Filtration Co., Ltd., Dingsheng Yunchuang Technology, Shenzhen Juke Investment Co., Ltd.
November 31, 2022
Share
Zhuhai Kairui Biotech Co., Ltd. announced that it has received CNY 100 million in its Series A round of funding on November 1, 2022. The transaction included participation from Juke Investment, Shanghai Yanghe Investment Management Co., Ltd., Guangzhou Jet Bio-Filtration Co., Ltd. and Dingsheng Yunchuang Technology.
Guangzhou Jet Bio-Filtration Co Ltd is a China-based company principally engaged in the research, development, production and sales of cell culture and related liquid handling life science consumables. The Company's main products include two categories of life science consumables, biological culture and liquid handling, as well as a small number of biological reagents, small laboratory instruments, protective equipment, medical devices and others. The Company's products are used in fields such as biomedicine, molecular diagnosis, medical protection, cell therapy, and biological research. The Company distributes its products within the domestic market and to overseas markets.
Zhuhai Kairui Biotech Co., Ltd. announced that it has received CNY 100 million in funding from Shanghai Yanghe Investment Management Co., Ltd., Guangzhou Jet Bio-Filtration Co., Ltd., Dingsheng Yunchuang Technology, Shenzhen Juke Investment Co., Ltd.
GUANGZHOU JET BIO-FILTRATION CO., LTD. 
